Psoriasis and Cardiovascular Comorbidities: Focusing on Severe Vascular Events, Cardiovascular Risk Factors and Implications for Treatment
Open accessThe DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
Abstract
Psoriasis is a common and chronic inflammatory disease of the skin. It may impair the physical and psychosocial function of patients and lead to decreased quality of life. Traditionally, psoriasis has been regarded as a disease affecting only the skin and joints. More recently, studies have shown that psoriasis is a systemic inflammatory disorder which can be associated with various comorbidities. In particular, psoriasis is associated with an increased risk of developing severe vascular events such as myocardial infarction and stroke. In addition, the prevalence rates of cardiovascular risk factors are increased, including hypertension, diabetes mellitus, dyslipidemia, obesity, and metabolic syndrome. Consequently, mortality rates have been found to be increased and life expectancy decreased in patients with psoriasis, as compared to the general population. Various studies have also shown that systemic treatments for psoriasis, including methotrexate and tumor necrosis factor-α inhibitors, may significantly decrease cardiovascular risk. Mechanistically, the presence of common inflammatory pathways, secretion of adipokines, insulin resistance, angiogenesis, oxidative stress, microparticles, and hypercoagulability may explain the association between psoriasis and cardiometabolic disorders. In this article, we review the evidence regarding the association between psoriasis and cardiovascular comorbidities, focusing on severe vascular events, cardiovascular risk factors and implications for treatment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin
(2002) · New England Journal of Medicine · doi:10.1056/nejmoa012512 · Cited by 19,011
Risk of myocardial infarction in patients with psoriasis
Gelfand, J. M., Neimann, A. L., Shin, D. B., Wang, X., Margolis, D. J., & Troxel, A. B. (2006) · JAMA · doi:10.1001/jama.296.14.1735 · Cited by 1,899 · cited 3×
“, 2006 [3] Myocardial infarction Mild psoriasis: 127,139; Severe psoriasis: 3837; Controls: 556,995 Relative risk: 30-year-old: Mild psoriasis: 1.”
MethodInfluentialOrchard, T. J., Temprosa, M., Goldberg, R., Haffner, S., Ratner, R., Marcovina, S., Fowler, S., & for the Diabetes Prevention Program Research Group (2005) · Annals of Internal Medicine · doi:10.7326/0003-4819-142-8-200504190-00009 · Cited by 948
Mehta, N. N., Azfar, R. S., Shin, D. B., Neimann, A. L., Troxel, A. B., & Gelfand, J. M. (2010) · European Heart Journal · doi:10.1093/eurheartj/ehp567 · Cited by 706
The Diabetes Prevention Program Research Group (2012) · Diabetes Care · doi:10.2337/dc11-1299 · Cited by 494
Ogdie, A., Yu, Y., Haynes, K., Love, T. J., Maliha, S., Jiang, Y., Troxel, A. B., Hennessy, S., Kimmel, S. E., Margolis, D. J., et al. (2015) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2014-205675 · Cited by 490 · cited 8×
“Another population-based cohort study performed in the United Kingdom found increased risk of major adverse cardiovascular events (including myocardial infarction, stroke and cardiovascular mortality) in patients with psoriasis [25].”
BackgroundInfluentialDowlatshahi, E. A., Wakkee, M., Arends, L. R., & Nijsten, T. (2014) · Journal of Investigative Dermatology · doi:10.1038/jid.2013.508 · Cited by 436 · cited 1×
“In addition, it is known that the psoriasis patients have a higher prevalence of depression [52,53], and the presence of depression has been shown to further increase the risk of myocardial infarction, stroke and cardiovascular mortality in patients with psoriasis [54].”
BackgroundThe 10-Year Cost-Effectiveness of Lifestyle Intervention or Metformin for Diabetes Prevention
The Diabetes Prevention Program Research Group (2012) · Diabetes Care · doi:10.2337/dc11-1468 · Cited by 436
PRODANOWICH, S., MA, F., TAYLOR, J., PEZON, C., FASIHI, T., & KIRSNER, R. (2005) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2004.06.017 · Cited by 384 · cited 2×
“, 2005 [251] Methotrexate Vascular disease (including cardiovascular disease, cerebrovascular disease, atherosclerosis) Psoriasis: 7615 Relative risk (compared to no methotrexate treatment): Methotrexate: 0.”
BackgroundPsoriasis and the Risk of Diabetes Mellitus: A Systematic Review and Meta-analysis
Armstrong, A. W., Harskamp, C. T., & Armstrong, E. J. (2013) · JAMA Dermatology · doi:10.1001/2013.jamadermatol.406 · Cited by 342
Dregan, A., Charlton, J., Chowienczyk, P., & Gulliford, M. C. (2014) · Circulation · doi:10.1161/circulationaha.114.009990 · Cited by 303 · cited 3×
“…disease (coronary heart disease, stroke, heart failure) Psoriasis: 262; Controls: 8009 Hazard ratio: 0.73 (95% CI 0.50–1.06) Netherlands/Prospectivecohort study Dregan et al., 2014 [45] Coronary heart disease Stroke Severe psoriasis: 5648; Mild psoriasis: 85,232; Controls: 373,851 Hazard…”
InfluentialWolf, N., Quaranta, M., Prescott, N. J., Allen, M., Smith, R., Burden, A. D., Worthington, J., Griffiths, C. E. M., Mathew, C. G., Barker, J. N., et al. (2008) · Journal of Medical Genetics · doi:10.1136/jmg.2007.053595 · Cited by 171
Dietary strategies implicated in the prevention and treatment of metabolic syndrome
De la Iglesia, R., Loria-Kohen, V., Zulet, M., Martinez, J., Reglero, G., & Ramirez de Molina, A. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17111877 · Cited by 168 · cited 1×
“Components of the metabolic syndrome include hyperglycemia, central/abdominal obesity, hypertension, and dyslipidemia (hypertriglyceridemia or low HDL level) [138,139].”
BackgroundYang, Z.-S., Lin, N.-N., Li, L., & Li, Y. (2016) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-016-8560-9 · Cited by 123 · cited 1×
“In addition, a number of studies have shown that treatment of psoriasis patients with TNF-α inhibitors leads to decreased risk of cardiovascular events compared to methotrexate, and greater risk reduction was found with longer duration of anti-TNF-α treatment [267,273].”
BackgroundPapagrigoraki, A., Giglio, M., Cosma, C., Maurelli, M., Girolomoni, G., & Lapolla, A. (2017) · Acta Dermato Venereologica · doi:10.2340/00015555-2661 · Cited by 46
Shaaban, D., & Al-Mutairi, N. (2018) · Journal of Dermatological Treatment · doi:10.1080/09546634.2016.1254145 · Cited by 18
Metadata
- Authors
- Hu, S., & Lan, C.-C. E.
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2017-10-21
- Volume
- 18
- Issue
- 10
- Pages
- 2211
- ISSN
- 1422-0067 (ISSN-L)
- OpenAlex
- W2766804418
- Cited by
- 199
- References
- 16
- FWCI
- 5.65
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.